论文部分内容阅读
作者报道了静脉注射或口服本品对威胁生命的或常规药物失败的小儿心律失常的治疗经验。 12例平均年龄8岁的患儿。7例于心动过速发作时静脉注射氟卡胺,极量为2 mg/kg,继以口服;全组12例的起始口服量为每日3～6mg/kg,极量每日22mg/kg。 4例有隐匿性旁路,服药后3例无复发;3例预激综合征,2例有效;2例希斯氏束心动过速(His bundle tachycardia)和3例室速均有效。心动过速发作时注射本品的7例中,4例恢复窦性心律;另外3例未转复,
The authors report the therapeutic experience of intravenous or oral administration of pediatric arrhythmias that are life-threatening or failed conventional drugs. 12 cases of children with an average age of 8 years old. 7 cases of tachycardia when intravenous injection of flecainide, the maximum amount of 2 mg / kg, followed by oral; whole group of 12 cases of the initial oral dose of 3 ~ 6mg / kg, the daily amount of 22mg / kg. 4 had occult bypass, 3 had no recurrence after taking the drug, 3 had Wolff-Parkinson’s syndrome, 2 were effective, 2 His bundle tachycardia and 3 VT were effective. Tachycardia attack injection of this product in 7 cases, 4 cases of sinus rhythm; the other 3 cases did not recover,